larg
amino
acid
l
polymeras
protein
nonseg
negativestrand
rna
virus
order
mononegaviral
six
conserv
sequenc
region
domain
postul
constitut
specif
enzymat
activ
involv
viral
mrna
synthesi
cap
cap
methyl
polyadenyl
genom
rna
replic
previou
studi
vesicular
stomat
viru
identifi
amino
acid
residu
within
l
protein
domain
vi
requir
mrna
cap
methyl
recent
studi
analyz
four
amino
acid
residu
within
domain
vi
sendai
viru
l
protein
data
indic
could
differ
l
protein
sequenc
requir
cap
methyl
two
differ
famili
mononegaviralesrhabdovirus
paramyxovirus
studi
conduct
comprehens
mutat
analysi
target
entir
sev
l
protein
domain
vi
creat
twentyfour
l
mutant
test
mutat
effect
viral
mrna
synthesi
cap
methyl
viral
genom
replic
viru
growth
kinet
analysi
identifi
sever
residu
requir
success
cap
methyl
viru
replic
clearli
show
import
kdke
tetrad
glycinerich
motif
sev
cap
methyl
studi
first
extens
sequenc
analysi
l
protein
domain
vi
famili
paramyxovirida
confirm
structur
function
similar
domain
across
differ
famili
order
mononegaviral
virus
order
mononegaviral
includ
divers
human
anim
plant
pathogen
share
structur
similar
nonseg
negativestrand
rna
genom
similar
strategi
viral
rna
genom
replic
transcript
posttranscript
modif
viral
mrna
lamb
park
lyle
rupprecht
whelan
et
al
member
order
encod
larg
l
polymeras
protein
six
highli
conserv
region
domain
postul
respons
specif
enzymat
activ
viral
polymeras
complex
includ
viral
genom
replic
transcript
mrna
cap
cap
methyl
polyadenyl
current
structur
data
avail
entir
l
region
l
howev
sitedirect
mutagenesi
comput
analys
support
multifunct
natur
l
protein
target
amino
acid
substitut
differ
l
domain
abl
inactiv
individu
function
viral
polymeras
carte
et
al
cortes
et
al
grdzelishvili
et
al
li
et
al
li
et
al
poch
et
al
schnell
conzelmann
sidhu
et
al
sleat
banerje
smallwood
et
al
similarli
eukaryot
mrna
mononegaviral
synthes
mrna
contain
cap
structur
methyl
posit
cap
requir
mrna
stabil
cap
methyl
especi
posit
requir
effici
mrna
translat
gingra
et
al
horikami
et
al
horikami
moyer
methyltransferas
mtase
activ
origin
map
l
protein
follow
character
two
vesicular
stomat
viru
vsv
famili
rhabdovirida
host
rang
hr
mutant
mutant
exhibit
sever
defect
cap
methyl
horikami
et
al
horikami
moyer
function
success
complement
purifi
wild
type
wt
l
protein
vitro
demonstr
l
possess
viral
mrna
mtase
activ
hercyk
et
al
recent
comput
analys
predict
l
protein
domain
vi
typic
mtase
fold
identifi
put
kdke
catalyt
tetrad
glycinerich
motif
gxgxg
put
adomet
bind
site
bujnicki
rychlewski
ferron
et
al
martin
mcmillan
predict
experiment
confirm
sever
studi
vsv
l
protein
lead
identif
amino
acid
residu
import
cap
methyl
within
domain
vi
galloway
et
al
grdzelishvili
et
al
li
et
al
li
et
al
grdzelishvili
et
al
show
one
vsv
hr
mutant
singl
substitut
v
virolog
within
glycinerich
motif
gdgsg
vsv
complet
defect
cap
methyl
sitedirect
mutagenesi
glycinerich
motif
put
kdke
catalyt
tetrad
li
et
al
li
et
al
show
import
mrna
cap
methyl
posit
previou
studi
suggest
l
protein
use
singl
adomet
bind
site
mtase
activ
least
vsv
methyl
preced
methyl
rahmeh
et
al
testa
banerje
cap
methyl
studi
conduct
use
vsv
limit
studi
use
sendai
viru
sev
famili
paramyxovirida
demonstr
similar
well
differ
cap
methyl
two
distantli
relat
virus
sev
produc
mrna
cap
methyl
posit
takagi
et
al
interestingli
purifi
sev
l
protein
ctermin
portion
retain
domain
vi
catalyz
cap
methyl
ogino
et
al
vsv
sev
alanin
substitut
lysin
upstream
glycinerich
motif
also
first
lysin
put
kdke
catalyt
tetrad
led
cap
methyl
defect
two
virus
murphi
grdzelishvili
howev
alanin
substitut
first
two
posit
glycinerich
motif
littl
effect
mtase
activ
sev
murphi
grdzelishvili
vsv
substitut
homolog
glycin
posit
affect
cap
methyl
either
posit
studi
vsv
also
identifi
region
upstream
domain
vi
import
cap
methyl
grdzelishvili
et
al
interestingli
recent
studi
show
vsv
toler
insert
gfp
gene
domain
vi
upstream
region
recombin
viru
insert
show
normal
growth
cell
cultur
virionassoci
activ
vitro
rueda
perrault
upstream
region
studi
sev
homolog
variabl
region
rhabdovirus
paramyxovirus
although
l
protein
measl
viru
paramyxoviru
also
report
toler
gfp
insert
region
upstream
domain
vi
duprex
et
al
dissect
l
protein
sequenc
requir
cap
methyl
sev
detail
conduct
comprehens
analysi
target
entir
sev
l
protein
domain
vi
creat
twentyfour
l
mutant
sitedirect
mutagenesi
highli
conserv
posit
within
domain
use
sequenc
conserv
l
protein
mononegaviral
guid
bujnicki
rychlewski
l
mutat
analyz
context
infecti
mutant
virus
effect
viral
mrna
cap
methyl
viru
growth
vitro
found
good
correl
attenu
cell
cultur
defect
mtase
activ
sev
mutant
analysi
experiment
confirm
previou
comput
predict
suggest
import
glycinerich
motif
kdke
tetrad
cap
methyl
across
differ
famili
order
mononegaviral
addit
major
l
mutant
test
abil
synthes
viral
mrna
replic
viral
genom
rna
studi
first
detail
analysi
l
protein
domain
vi
famili
paramyxovirida
sitedirect
mutagenesi
sev
l
protein
domain
recoveri
infecti
sev
mutant
recent
studi
use
sev
target
four
amino
acid
residu
domain
vi
show
discrep
vsv
sev
l
protein
sequenc
requir
cap
methyl
murphi
grdzelishvili
work
analyz
entir
domain
vi
sev
detail
target
residu
highli
conserv
member
order
mononegaviral
fig
addit
target
glycinerich
motif
put
adomet
bind
site
put
catalyt
tetrad
kdke
also
conserv
known
mtase
includ
protein
flavivirus
fig
also
target
residu
locat
upstream
glycinerich
motif
conserv
paramyxovirus
fig
mani
class
mtase
known
structur
contain
either
conserv
aspart
glutam
tyrosin
residu
within
beta
strand
preced
conserv
glycinerich
motif
rare
contain
residu
polar
residu
posit
implic
reaction
mechan
fifth
catalyt
entiti
kozbial
mushegian
interest
determin
whether
one
amino
acid
may
play
function
role
sev
mtase
also
target
dkdk
sequenc
locat
immedi
upstream
residu
although
dkdkd
sequenc
present
paramyxovirus
want
determin
whether
high
concentr
aspart
lysin
close
proxim
glycinerich
motif
may
play
role
cap
methyl
catalysi
addit
singl
amino
acid
substitut
sever
doubl
tripl
alanin
substitut
creat
glycin
within
glycinerich
motif
chang
leucin
address
possibl
motif
import
cap
methyl
sev
toler
singl
glycinetoalanin
substitut
compar
vsv
told
twentyfour
l
mutant
gene
gener
context
pgeml
vector
l
gene
control
promot
analysi
use
system
see
addit
clone
mutat
sev
fulllength
antigenom
plasmid
abl
gener
infecti
sev
mutant
use
revers
genet
system
tabl
infecti
viru
particl
could
recov
remain
five
mutant
l
gene
indic
nr
tabl
infecti
sev
mutant
initi
test
abil
infect
produc
cytopath
effect
cpe
vero
cell
infecti
foci
visual
crystal
violet
stain
h
pi
sever
mutant
behav
similarli
rwt
mutant
obviou
defect
growth
base
inabl
form
visibl
infecti
foci
fig
mutant
substitut
posit
dkdkdr
capabl
form
visibl
infecti
foci
grew
rwtlike
titer
fig
tabl
mutant
doublemut
behav
previou
report
murphi
grdzelishvili
ie
show
similar
growth
rwt
even
mutant
slight
delay
growth
still
grew
high
titer
addit
alanin
mutant
around
glycinerich
motif
behav
minor
variat
especi
tripl
mutant
smaller
rwt
infecti
foci
grew
high
titer
ciuml
mutant
small
infecti
foci
h
pi
h
pi
foci
size
titer
similar
rwt
fig
contrast
mutant
leucin
substitut
dramat
effect
viru
growth
could
recov
despit
effort
dramat
attenu
vero
cell
infecti
foci
could
detect
fig
sever
attenu
cell
cultur
even
sever
passag
vero
cell
titer
remain
extrem
low
ciuml
fig
tabl
thu
gxgxg
motif
case
homolog
mtase
known
structur
invari
locat
loop
first
beta
strand
alpha
helix
rossmann
fold
toler
substitut
small
side
chain
residu
alanin
bulkier
aliphat
side
chain
leucin
appear
incompat
structur
function
region
rule
similar
neg
charg
turn
unimport
viru
viabil
even
though
residu
conserv
mononegaviral
bulki
aliphat
leucin
residu
toler
report
previous
sev
l
mutant
alanin
substitut
first
posit
put
kdke
catalyt
tetrad
attenu
cell
cultur
murphi
grdzelishvili
creat
alanin
substitut
posit
motif
rescu
virus
substitut
posit
howev
abl
rescu
viru
mutat
interestingli
sequenc
posit
mutant
substitut
serin
alanin
serin
substitut
appar
select
vivo
input
plasmid
use
viru
recoveri
confirm
sequenc
alanin
substitut
addit
target
kdke
tetrad
creat
alanin
mutant
two
posit
invari
mononegaviral
doubl
mutant
sev
l
mutant
substitut
around
put
kdke
catalyt
tetrad
attenu
grown
vero
cell
fig
produc
infecti
foci
detect
fig
amino
acid
kdke
tetrad
wide
space
sequenc
viru
mtase
brought
close
distanc
homolog
mtase
known
structur
predict
spatial
structur
l
domain
vi
protein
bujnicki
rychlewski
galloway
et
al
form
semicircl
outer
rim
adomet
bind
pocket
thought
work
togeth
transfer
methyl
group
donor
nucleotid
viru
mrna
though
exact
role
residu
well
detail
reaction
mechan
inde
nativ
threedimension
structur
mtase
mononegaviral
remain
investig
residu
predict
outward
adomet
bind
pocket
may
expect
interact
methyl
donor
rather
perhap
multipl
align
conduct
use
alibe
multipl
align
program
genebe
websit
wwwgenebeemsusugenebeehtml
brodski
et
al
kdke
glycinerich
motif
mutat
posit
highlight
black
gray
shadow
indic
amino
acid
substitut
gener
studi
play
role
recognit
rna
substrat
result
indic
singl
alanin
mutat
residu
result
attenu
viru
infect
also
recov
sever
mutant
alanin
substitut
invari
posit
domain
vi
ie
mutant
virus
behav
similarli
rwt
vero
cell
grew
high
titer
fig
tabl
correspond
residu
predict
locat
outsid
ligandbind
pocket
may
involv
intramolecular
interact
howev
unabl
recov
viru
progeni
mutant
multipl
alanin
substitut
patch
amino
acid
predict
face
outward
ie
tripl
substitut
doubl
substitut
highli
conserv
region
might
necessari
interact
sev
mtase
region
within
l
protein
protein
examin
growth
characterist
rescu
mutant
virus
onestep
growth
kinet
analysi
perform
describ
materi
method
fig
rwt
reach
highest
titer
h
pi
declin
h
pi
mutant
substitut
within
dkdkd
sequenc
upstream
glycinerich
motif
slightli
lower
titer
rwt
overal
still
reach
highest
titer
h
pi
fig
mutant
substitut
glycinerich
motif
major
behav
similarli
rwt
slightli
lower
titer
overal
maximum
titer
ciuml
reach
h
pi
fig
sever
attenu
infecti
particl
detect
h
pi
maximum
titer
reach
ciuml
h
pi
l
mutant
substitut
around
put
kdke
catalyt
tetrad
delay
growth
dramat
lower
maximum
titer
ciu
ml
compar
rwt
determin
whether
l
mutat
affect
abil
virus
methyl
mrna
cap
structur
vitro
transcript
perform
use
detergentactiv
purifi
virion
presenc
h
adomet
without
sadenosylhomocystein
adohci
competit
inhibitor
adometdepend
mtase
rna
product
isol
analyz
scintil
count
h
adomet
incorpor
northern
blot
total
mrna
level
tabl
cap
methyl
activ
l
mutant
protein
express
ratio
h
adomet
incorpor
viral
mrna
np
p
mrna
product
tabl
column
normal
done
account
variabl
overal
transcript
level
differ
virus
tabl
column
variabl
could
due
mutat
specif
effect
viral
mrna
synthesi
due
variabl
transcript
activ
individu
virion
prepar
see
unfortun
highresolut
analysi
cap
structur
sev
mrna
beyond
reach
due
lower
abund
mrna
produc
sev
virionassoci
l
protein
compar
vsv
murphi
grdzelishvili
howev
confirm
h
label
sev
mrna
tabl
methyl
cap
structur
analyz
h
adomet
label
mrna
gener
describ
use
tobacco
acid
pyrophosphatas
tap
fig
tap
commonli
use
specif
remov
adohci
vitro
transcript
absenc
sadenosylhomocystein
adohci
adohci
vitro
transcript
presenc
adohci
methyl
viral
mrna
np
p
produc
vitro
express
ratio
rwt
h
adomet
incorpor
viral
mrna
scintil
count
mrna
level
determin
analyz
northern
blot
mrna
level
shown
txn
column
nr
rescu
unabl
rescu
multipl
attempt
nd
determin
virus
also
analyz
previou
studi
murphi
grdzelishvili
ciu
cell
infecti
unit
data
repres
mean
standard
deviat
two
independ
experi
guanosin
monophosph
cap
mrna
uncap
mrna
serv
substrat
tap
shinshi
et
al
addit
sev
mrna
use
three
differ
control
mrna
confirm
tap
specif
hydrolyz
phosphor
acid
anhydrid
bond
triphosph
bridg
cap
structur
importantli
tap
treatment
clearli
result
releas
h
g
sev
mrna
produc
determentactiv
virion
vitro
indic
sev
mrna
least
partial
methyl
posit
similar
result
obtain
vsv
virionproduc
mrna
consist
previou
studi
demonstr
fulli
methyl
vsv
mrna
cap
structur
abraham
et
al
rahmeh
et
al
testa
banerje
although
data
fig
demonstr
sev
methyl
mrna
least
partial
posit
point
make
conclus
cap
structur
sev
mrna
produc
experiment
condit
fig
show
tap
releas
h
g
sev
mrna
vsv
mrna
similar
amount
h
g
releas
sev
mrna
synthet
cap
mrna
could
indic
sev
methyl
exclus
posit
howev
would
prematur
make
conclus
base
sole
tap
experi
thu
observ
complet
remov
h
g
synthet
cap
mrna
label
posit
indic
experiment
condit
tap
effect
hydrolyz
triphosph
bridg
furthermor
mrna
product
analyz
fig
normal
h
count
howev
like
effici
cap
methyl
differ
sev
vsv
vaccinia
viru
mtase
therefor
differ
molar
amount
cap
mrna
like
present
reaction
complic
conclus
cap
structur
studi
use
altern
biochem
assay
need
determin
cap
structur
sev
mrna
produc
experiment
condit
although
dramat
improv
vitro
transcript
condit
need
obtain
suffici
amount
viral
mrna
cap
analysi
sev
l
mutant
dkdkd
sequenc
methyl
level
similar
rwt
decreas
cap
methyl
compar
rwt
consist
previou
result
murphi
grdzelishvili
sev
l
mutant
slightli
decreas
methyl
compar
rwt
mutant
methyl
level
rwt
sev
l
mutant
glycinerich
motif
lower
level
methyl
compar
rwt
rang
except
sev
l
mutant
substitut
around
kdke
tetrad
sever
defect
cap
methyl
rwt
gener
sev
mutant
defect
cap
methyl
attenu
vero
cell
indic
import
function
sev
life
cycl
interestingli
rwt
mutant
show
residu
mrna
methyl
presenc
adohci
valu
surprisingli
high
point
explan
result
consist
reproduc
sever
independ
experi
exclud
interest
possibl
mutat
improv
prefer
l
toward
adomet
adohci
make
less
sensit
excess
product
studi
need
address
possibl
analysi
abil
express
l
protein
synthes
viral
mrna
replic
genom
rna
vitro
examin
abil
l
mutant
synthes
viral
genom
negativestrand
well
mrna
select
differ
mutat
result
viru
attenu
vero
cell
low
cap
methyl
level
rescu
phenotyp
tabl
analyz
effect
mutat
l
function
use
plasmid
base
express
assay
depend
viabil
sev
mutant
virus
assay
base
exogen
provid
polymerasefre
wt
genom
transcript
di
replic
rnan
templat
cell
extract
contain
rna
polymeraseexpress
sev
l
wt
mutant
p
np
di
replic
protein
describ
materi
method
briefli
cell
infect
vaccinia
viru
vv
express
polymeras
transfect
sev
p
wt
l
wt
mutant
np
wt
di
replic
incub
h
pt
cytoplasm
extract
contain
pl
nppl
complex
prepar
suppli
exogen
wt
sev
polymerasefre
rnan
templat
genom
di
p
ctp
assay
mrna
di
rna
synthesi
agreement
put
lethal
phenotyp
unabl
rescu
mutant
virus
mutat
independ
attempt
two
l
mutat
well
earlier
describ
mutant
sev
l
protein
entir
domain
vi
delet
murphi
grdzelishvili
produc
detect
mrna
also
defect
genom
rna
replic
rwt
fig
mutant
l
protein
could
also
rescu
vivo
wtlike
level
transcript
vvmediat
system
replic
level
rwt
sever
mutant
l
protein
transcript
level
higher
rwt
lower
level
replic
rwt
includ
member
kdke
catalyt
tetrad
member
glycinerich
motif
similar
level
transcript
replic
rang
rwt
intriguingli
mutant
less
activ
transcript
replic
even
though
virion
bear
mutat
recov
grew
similar
titer
compar
rwt
indic
intact
primari
adomet
bind
site
major
catalyt
residu
requir
multipl
function
l
protein
like
includ
synthesi
negativestrand
genom
rna
transcript
mrna
two
mutant
l
protein
rwt
level
transcript
replic
indic
limit
role
predict
first
helix
rossmann
fold
sev
rna
synthesi
interestingli
observ
mani
amino
acid
substitut
neg
affect
l
protein
accumul
plasmid
base
express
assay
mutat
could
potenti
affect
l
gene
express
l
protein
stabil
protein
could
impact
viral
rna
synthesi
howev
see
clear
correl
l
protein
level
transcript
activ
mutant
protein
fig
interestingli
lowest
protein
accumul
wt
shown
mutat
howev
transcript
activ
time
mutant
show
di
replic
activ
suggest
possibl
l
protein
accumul
may
specif
affect
replic
transcript
activ
viral
polymeras
howev
two
mutat
disproport
low
di
replic
activ
rel
transcript
show
dramat
decreas
protein
accumul
fig
test
whether
sev
mutant
substitut
differ
posit
within
domain
vi
could
potenti
complement
grown
togeth
infect
vero
cell
variou
combin
defect
mutant
moi
ciucel
per
viru
total
moi
condit
cell
coinfect
virus
addit
virus
phenotyp
describ
includ
rwt
mutant
behav
similarli
rwt
control
see
increas
cpe
defect
mutant
combin
defect
mutant
data
shown
instead
two
defect
mutant
combin
rwt
observ
inhibit
cpe
less
cell
round
cell
remain
attach
plastic
data
shown
suggest
interf
rwt
replic
investig
repeat
experi
look
sev
l
methyl
defect
mutant
combin
rwt
fig
combin
grew
titer
compar
supernat
collect
vero
cell
infect
rwt
except
lower
titer
rwt
rwt
foci
easili
discrimin
gener
mutant
due
significantli
larger
size
earlier
appear
compar
growth
kinet
two
mutant
combin
rwt
infect
vero
cell
collect
supernat
h
pi
similar
titrat
experi
fig
combin
rwt
similar
growth
kinet
rwt
alon
combin
rwt
delay
growth
lower
maxim
titer
fig
indic
cap
methyl
defect
alon
suffici
interfer
rwt
replic
addit
factor
involv
dominantneg
phenotyp
sev
mutant
time
explain
virus
contain
amino
acid
substitut
l
posit
interfer
rwt
replic
one
possibl
inhibit
may
simpli
reflect
elev
level
fig
vitro
mrna
synthesi
genom
replic
sev
mutant
l
protein
use
express
system
plasmid
express
p
wt
mutant
l
protein
transfect
infect
cell
n
protein
also
express
di
replic
total
rna
isol
cell
lysat
vitro
transcript
di
replic
b
reaction
perform
presenc
ctp
western
blot
analys
cell
lysat
use
b
demonstr
rel
express
sev
l
p
n
di
replic
protein
cell
transcript
di
replic
data
repres
mean
standard
deviat
two
independ
experi
di
particl
gener
mutant
test
hypothesi
infect
vero
cell
fig
collect
cell
medium
h
pi
consist
fig
inhibit
product
rwt
determin
titrat
collect
medium
fresh
vero
cell
fig
analysi
rna
synthes
superinfect
collect
supernat
cell
analyz
northern
blot
describ
materi
method
detect
di
genom
probe
complimentari
first
sev
genom
rna
use
abl
detect
fulllength
genom
rna
sev
well
di
genom
independ
mechan
gener
shown
fig
unabl
detect
di
genom
vero
cell
experiment
condit
interestingli
despit
clear
inhibit
sev
rwt
virion
product
fig
see
statist
signific
decreas
sev
np
mrna
accumul
superinfect
cell
fig
use
probe
code
np
gene
sequenc
although
modest
decreas
fulllength
genom
rna
wt
plu
mutant
level
observ
fig
fl
grna
band
pellet
analyz
northern
blot
analysi
genom
rna
use
probe
fulllength
fl
genom
rna
grna
well
di
genom
rna
riboprob
sev
np
mrna
well
fl
antigenom
rna
agrna
e
describ
materi
method
vero
mock
sampl
total
rna
isol
mockinfect
vero
cell
total
rna
use
sampl
vero
wt
sev
sampl
total
rna
isol
vero
cell
infect
sev
rwt
collect
h
pi
di
grna
sampl
total
rna
isol
prepar
sev
di
particl
dih
prepar
particl
contain
fl
genom
rna
similar
lack
di
genom
modest
reduct
fulllength
genom
rna
level
observ
viru
particl
medium
pellet
ultracentrifug
rna
particl
analyz
northern
blot
data
shown
togeth
data
suggest
abl
overcompet
rwt
superinfect
mechan
unclear
effect
appar
diindepend
studi
detail
sequencefunct
analysi
l
protein
domain
vi
paramyxovirus
earlier
mutagenesi
studi
awar
despit
differ
vsv
sev
present
recent
studi
murphi
grdzelishvili
result
clearli
show
import
put
catalyt
tetrad
kdke
glycinerich
motif
thu
confirm
previou
comput
predict
region
import
mtase
function
across
differ
famili
order
mononegaviral
bujnicki
rychlewski
ferron
et
al
martin
mcmillan
analyz
domain
vi
conduct
sitedirect
mutagenesi
target
residu
highli
conserv
among
mononegaviral
includ
kdke
tetrad
glycinerich
motif
also
present
known
cap
mtase
includ
protein
flavivirus
fig
nonstructur
protein
coronavirus
decroli
et
al
similar
vsv
alanin
substitut
put
kdke
catalyt
tetrad
sev
gener
mutant
virus
defect
cap
methyl
kdke
tetrad
previous
shown
catalyz
methyl
transfer
known
mtase
includ
protein
flavivirus
bollati
et
al
egloff
et
al
ray
et
al
selisko
et
al
nonstructur
protein
coronavirus
bouvet
et
al
decroli
et
al
west
nile
viru
wnv
flaviviru
amino
acid
substitut
homolog
residu
abolish
cap
methyl
protein
modest
effect
methyl
ray
et
al
zhou
et
al
vsv
similar
substitut
abolish
methyl
li
et
al
discrep
wnv
vsv
explain
differ
order
methyl
event
shown
flavirus
gpppa
gpppa
gppp
zhou
et
al
vsv
gpppa
gpppam
gppp
rahmeh
et
al
testa
banerje
inactiv
methyl
significantli
affect
methyl
wnv
prevent
vsv
methyl
preced
appar
facilit
subsequ
methyl
rahmeh
et
al
highresolut
analysi
cap
structur
sev
mrna
still
beyond
reach
due
lower
abund
mrna
produc
sev
virionassoci
l
protein
compar
vsv
murphi
grdzelishvili
howev
critic
import
kdke
tetrad
overal
cap
methyl
sev
present
studi
may
indic
sev
l
protein
catalyz
cap
methyl
use
order
vsv
data
also
demonstr
import
glycinerich
motif
put
adomet
bind
site
domain
vi
sev
cap
methyl
differ
effect
mutat
glycinerich
motif
sev
compar
vsv
vsv
shown
virion
alanin
substitut
first
two
glycin
decreas
cap
methyl
alanin
substitut
third
glycin
affect
mtase
activ
determin
third
glycin
glycinerich
motif
seem
play
signific
role
cap
methyl
sev
vsv
decreas
cap
methyl
compar
rwt
confirm
import
posit
tripl
mutant
three
glycin
substitut
alanin
also
low
methyl
level
rwt
doubl
mutant
first
two
glycin
substitut
alanin
rwtlike
level
growth
higher
methyl
previou
partial
result
show
much
toler
substitut
first
two
glycin
glycinerich
motif
even
doubt
function
adomet
bind
site
murphi
grdzelishvili
data
present
includ
role
third
glycin
sev
cap
methyl
dramat
effect
glycinetoleucin
substitut
motif
restor
convent
view
role
conserv
sequenc
motif
anoth
mutat
result
defect
cap
methyl
rwt
viru
attenu
residu
never
studi
mononegaviral
highli
conserv
paramyxovirus
possess
hydroxyl
group
may
substitut
aspart
glutam
acid
residu
frequent
found
middl
first
beta
strand
rossmann
fold
propos
kozbial
mushegian
side
chain
residu
make
either
direct
water
moleculemedi
contact
methionin
portion
adomet
may
directli
involv
catalysi
sever
paramyxovirus
next
residu
motif
potenti
import
catalysi
due
high
concentr
aspart
lysin
close
proxim
glycinerich
motif
target
posit
substitut
alanin
sev
l
mutant
easili
recov
grew
high
titer
similar
kinet
rwt
vero
cell
high
level
cap
methyl
consist
role
cap
methyl
translat
mrna
sev
mutant
decreas
methyl
attenu
vero
cell
major
mutant
substitut
around
put
kdke
catalyt
tetrad
agreement
recent
studi
murphi
grdzelishvili
observ
alanin
substitut
posit
around
glycinerich
motif
well
toler
howev
tripl
mutant
three
glycin
replac
alanin
show
slight
attenu
confirm
import
motif
sev
l
function
viru
replic
also
observ
two
cap
methyl
defect
mutant
strong
interf
effect
replic
wt
sev
superinfect
interestingli
anoth
cap
methyl
defect
mutant
interfer
rwt
replic
indic
cap
methyl
defect
alon
suffici
dominantneg
mutant
phenotyp
addit
factor
involv
current
explain
mutat
could
inhibit
growth
rwt
studi
warrant
explor
interest
observ
interestingli
singl
alanin
substitut
put
catalyt
posit
success
introduc
plasmid
contain
sev
l
gene
fulllength
antigenom
sev
howev
infecti
viru
particl
recov
use
revers
genet
system
sequenc
substitut
serin
rather
alanin
base
import
posit
catalyt
tetrad
specul
chang
polar
serin
residu
led
favor
configur
hydrogen
bond
network
link
catalyt
residu
adomet
perhap
addit
support
proper
conform
l
protein
may
import
function
test
vitro
transcript
replic
system
mutant
l
slightli
lower
transcript
lower
replic
level
compar
rwt
mutant
virion
substitut
defect
cap
methyl
rwt
high
transcript
level
rwt
appar
serin
substitut
favor
overal
activ
l
protein
although
necessarili
cap
methyl
better
understand
biolog
sev
l
mutant
could
lead
ration
design
live
attenu
virus
use
vaccin
oncolyt
gene
therapi
vector
base
differ
member
mononegaviral
african
green
monkey
vero
atcc
human
lung
carcinoma
atcc
cell
deriv
babi
hamster
kidney
cell
constitut
express
bacteriophag
polymeras
buchholz
et
al
use
viru
infect
plasmid
transfect
virusdriven
express
bacteriophag
rna
polymeras
cell
infect
vaccinia
viru
fuerst
et
al
recombin
wt
rwt
sev
fushimi
strain
leyrer
et
al
kindli
provid
dr
wolfgang
j
neubert
maxplanckinstitut
biochemistri
germani
sev
rwt
mutant
grown
purifi
describ
murphi
grdzelishvili
sev
infect
measur
viru
titrat
vero
cell
express
cell
infecti
unitsml
ciuml
faster
grow
sev
mutant
well
stain
crystal
violet
formalin
min
wash
pb
dri
immunofluoresc
assay
use
sever
attenu
sev
mutant
describ
murphi
grdzelishvili
follow
hoechst
reagent
invitrogen
ad
well
min
cell
wash
pb
view
fluoresc
microscop
onestep
growth
kinet
vero
cell
incub
hour
h
sev
wt
mutant
moi
ciucel
well
plate
h
post
infect
pi
unabsorb
virus
aspir
cell
wash
two
time
pb
megavir
serumfre
medium
sfm
hyclon
acetyl
trypsin
sigma
ad
well
plaqu
assay
perform
vero
cell
use
supernat
collect
differ
time
point
superinfect
experi
viru
infect
foci
detect
describ
murphi
grdzelishvili
cn
peroxidas
substrat
colorimetr
stain
kpl
briefli
cell
fix
paraformaldehyd
sigma
min
permeabil
min
ice
cell
block
pb
bovin
serum
albumin
sigma
min
incub
antisev
primari
antibodi
h
cell
wash
incub
goat
antirabbit
igghrp
jackson
immunoresearch
secondari
antibodi
h
visual
infecti
foci
cell
wash
incub
equal
volum
cn
peroxidas
substrat
peroxidas
substrat
solut
b
kpl
pgem
plasmid
contain
wt
gene
sev
np
l
pstop
express
p
c
due
stop
codon
c
open
read
frame
refer
wt
p
control
promot
describ
previous
curran
et
al
pgeml
plasmid
use
sitedirect
mutagenesi
describ
murphi
grdzelishvili
sev
ptmnp
ptmp
ptml
plasmid
leyrer
et
al
fulllength
sev
antigenom
plasmid
use
rescu
recombin
sev
virus
kindli
provid
dr
wolfgang
j
neubert
maxplanckinstitut
biochemistri
germani
sev
l
protein
mutat
introduc
describ
murphi
grdzelishvili
recombin
virus
purifi
grdzelishvili
et
al
mutat
confirm
sequenc
analysi
presenc
desir
mutat
absenc
spontan
secondari
mutat
l
gene
total
protein
concentr
purifi
virion
determin
bradford
assay
use
conjunct
viral
titer
determin
infect
per
total
protein
produc
cell
lysat
contain
sev
wt
p
wt
mutant
l
protein
vitro
transcript
dish
cell
infect
vaccinia
viru
vv
moi
ciucel
h
wash
optimem
gibco
transfect
sev
pgempstop
pgeml
wt
l
one
mutant
l
gene
plasmid
use
lipofectamin
invitrogen
incub
optimem
h
pt
cytoplasm
extract
prepar
exactli
describ
previous
chandrika
et
al
grdzelishvili
et
al
assay
sev
mrna
synthesi
wt
sev
polymerasefre
rnan
templat
p
ctp
ad
extract
reaction
incub
h
produc
cell
lysat
contain
sev
wt
np
wt
p
wt
mutant
l
protein
vitro
replic
sev
defect
interf
di
rna
dish
cell
infect
transfect
use
sev
pgempstop
sev
pgemnp
pgeml
wt
l
one
mutant
l
gene
h
pt
cytoplasm
extract
prepar
vitro
transcript
assay
sev
genom
synthesi
deterg
disrupt
dih
carlsen
et
al
p
ctp
ad
extract
reaction
incub
h
treat
micrococc
nucleas
digest
unpackag
rna
mrna
vitro
transcript
di
replic
total
rna
purifi
use
quickrna
miniprep
zymo
research
analyz
urea
gel
electrophoresi
gel
fix
acet
acid
dri
quantit
use
typhoon
phosphorimag
imagequ
softwar
molecular
dynam
sev
vitro
transcript
detergentactiv
purifi
virion
conduct
describ
murphi
grdzelishvili
test
viral
mrna
cap
methyl
rna
synthes
reaction
cold
ntp
mm
h
adomet
cimmol
adomet
final
concentr
presenc
absenc
methyl
inhibitor
sadenosylhomocystein
adohci
total
rna
purifi
use
mini
rna
isol
ii
kit
zymo
research
dilut
dih
use
measur
h
adomet
incorpor
scintil
count
analyz
northern
blot
measur
viral
mrna
level
gener
viral
mrna
cap
analysi
use
tobacco
acid
pyrophosphatas
tap
sev
rwt
vsv
rwt
vitro
transcript
detergentactiv
purifi
virion
perform
describ
use
h
adomet
reaction
condit
sev
vsv
vsv
mrna
synthes
reaction
obtain
suffici
amount
sev
mrna
analysi
ten
transcript
reaction
use
sev
rwt
viral
mrna
product
isol
pool
togeth
tap
treatment
prepar
synthet
mrna
control
uncap
sev
np
mrna
synthes
vitro
maxiscript
kit
ambion
use
sev
plasmid
digest
bamhi
restrict
site
locat
immedi
stop
codon
np
gene
templat
rna
divid
gener
cap
contain
mrna
gpppa
tap
analysi
virionproduc
viral
mrna
sev
vsv
synthet
label
mrna
normal
h
count
digest
tap
epicentr
biotechnolog
reaction
presenc
absenc
u
tap
h
reaction
adjust
pass
sephadex
minicolumn
spin
column
place
new
microfug
tube
dih
pass
column
retriev
residu
columnbound
rna
separ
optim
experi
demonstr
effect
separ
rna
nucleotid
use
procedur
data
shown
h
met
incorpor
cap
posit
measur
scintil
count
entir
flow
contain
mrna
sephadex
column
materi
remov
minicolumn
separ
contain
remov
g
northern
blot
analysi
conduct
describ
murphi
grdzelishvili
measur
mrna
level
vitro
transcript
reaction
h
adomet
describ
briefli
mrna
product
separ
agaroseformaldehyd
gel
transfer
hybondn
nylon
membran
ge
healthcar
incub
rna
probe
complementari
sev
np
gene
probe
synthes
digest
sev
plasmid
ecorv
restrict
site
transcrib
vitro
presenc
p
ctp
use
maxiscript
kit
ambion
analysi
rna
synthes
superinfect
supernat
cell
collect
h
pi
viru
particl
supernat
pellet
centrifug
rpm
h
use
beckman
tla
rotor
total
rna
extract
cell
pellet
virion
use
zymo
research
quickrna
miniprep
kit
total
rna
supernat
cell
respect
separ
agaroseformaldehyd
gel
transfer
nylon
membran
membran
origin
probe
full
length
di
genom
rna
use
oligonucleotid
integr
dna
technolog
complimentari
first
sev
genom
rna
primer
label
p
atp
use
bacteriophag
polynucleotid
kinas
new
england
biolab
membran
reprob
np
mrna
use
riboprob
describ
radioact
signal
measur
use
typhoon
phosphorimag
imagequ
softwar
molecular
dynam
compar
amount
p
l
protein
cell
lysat
use
vitro
transcript
total
protein
sampl
transfect
cytoplasm
lysat
separ
sdspage
electroblot
onto
polyvinyliden
difluorid
membran
pvdf
sigma
membran
block
nonfat
dri
milk
tbst
nacl
mm
tri
ph
tween
antibodi
dilut
buffer
blot
initi
incub
mixtur
rabbit
antibodi
sev
l
protein
atrpesevl
atrpesevl
horikami
et
al
develop
horseradish
peroxidaseconjug
secondari
antibodi
use
enhanc
chemiluminesc
plu
protein
detect
system
ge
healthcar
accord
manufactur
instruct
blot
reprob
rabbit
antisev
antibodi
carlsen
et
al
develop
manner
protein
band
quantifi
use
visionworksl
softwar
uvp
